AMRX vs CMCSA · P/E 44, rev $1.52B vs P/E 8.6, rev $61.40B
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) versus Comcast Corp (CMCSA) — a side-by-side from cached financials, not a winner call.
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Comcast Corp (CMCSA) is a telecom services company listed on US. It is led by Brian Roberts.
Latest reported AMRX revenue for 2026-06-30 was $1.52B. Net income was $119.9M. AMRX currently screens at market cap $5.19B and trailing P/E 44.0.
Latest reported CMCSA revenue for 2026-06-30 was $61.40B. Net income was $5.70B. Revenue was up 95.2% from 2026-03-31 to 2026-06-30. CMCSA currently screens at market cap $130.64B and trailing P/E 8.6.
AMRX currently screens at market cap $5.19B and trailing P/E 44.0. CMCSA currently screens at market cap $130.64B and trailing P/E 8.6.
Not investment advice. Open the AMRX and CMCSA stock pages for the full models.
Not investment advice.